作者
Chantal BF Vogels, Anderson F Brito, Anne L Wyllie, Joseph R Fauver, Isabel M Ott, Chaney C Kalinich, Mary E Petrone, Arnau Casanovas-Massana, M Catherine Muenker, Adam J Moore, Jonathan Klein, Peiwen Lu, Alice Lu-Culligan, Xiaodong Jiang, Daniel J Kim, Eriko Kudo, Tianyang Mao, Miyu Moriyama, Ji Eun Oh, Annsea Park, Julio Silva, Eric Song, Takehiro Takahashi, Manabu Taura, Maria Tokuyama, Arvind Venkataraman, Orr-El Weizman, Patrick Wong, Yexin Yang, Nagarjuna R Cheemarla, Elizabeth B White, Sarah Lapidus, Rebecca Earnest, Bertie Geng, Pavithra Vijayakumar, Camila Odio, John Fournier, Santos Bermejo, Shelli Farhadian, Charles S Dela Cruz, Akiko Iwasaki, Albert I Ko, Marie L Landry, Ellen F Foxman, Nathan D Grubaugh
发表日期
2020/10
期刊
Nature microbiology
卷号
5
期号
10
页码范围
1299-1305
出版商
Nature Publishing Group
简介
The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies the critical need for accurate and rapid diagnostic assays to prompt clinical and public health interventions. Currently, several quantitative reverse transcription–PCR (RT–qPCR) assays are being used by clinical, research and public health laboratories. However, it is currently unclear whether results from different tests are comparable. Our goal was to make independent evaluations of primer–probe sets used in four common SARS-CoV-2 diagnostic assays. From our comparisons of RT–qPCR analytical efficiency and sensitivity, we show that all primer–probe sets can be used to detect SARS-CoV-2 at 500 viral RNA copies per reaction. The exception for this is the RdRp-SARSr (Charité) confirmatory primer–probe set which has low sensitivity, probably due to a mismatch to circulating SARS-CoV-2 in the reverse primer …
引用总数
学术搜索中的文章